Correlation of Programmed Death-Ligand 1 Expression With Lung Adenocarcinoma Histologic and Molecular Subgroups in Primary and Metastatic Sites
Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Navneet Narula(The University of Texas Health Science Center), André L. Moreira(NYU Langone Health), Kyung Park(Cornell University), Fang Zhou(Hunan Cancer Hospital), Atreyee Basu(Tufts Medical Center)
Cited by 8
Related Papers
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
The Integrated Genomic Landscape of Thymic Epithelial Tumors
|Cancer Cell|2018|389
Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of <i>EGFR</i> / <i>KRA</i> S and Presence of <i>PIK3CA</i> / <i>AKT1</i> Mutations
|Clinical Cancer Research|2012|365
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
|Journal of Thoracic Oncology|2018|350
A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors
|The American Journal of Surgical Pathology|2010|330